Paul M. Michael
Président chez CURATIVE BIOTECHNOLOGY, INC.
Postes actifs de Paul M. Michael
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CURATIVE BIOTECHNOLOGY, INC. | Président | 11/02/2021 | - |
| President | 11/02/2021 | - | |
| Directeur/Membre du Conseil | - | 11/02/2021 | |
| Directeur Général | - | 11/02/2021 |
Historique de carrière de Paul M. Michael
Anciens postes connus de Paul M. Michael
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PALISADE BIO, INC. | Fondateur | - | - |
Nobelpharma Co., Ltd.
 Nobelpharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Nobelpharma Co., Ltd. provides research and development of pharmaceuticals for unmet needs. Its product line encompasses orphan drugs, medicines used for additional efficacy, and pediatric medicines. The company was founded on June 6, 2003 and is headquartered in Tokyo, Japan. | Fondateur | - | - |
Statistiques
Internationale
| Etats-Unis | 3 |
| Japon | 2 |
Opérationnelle
| Founder | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectorielle
| Health Technology | 3 |
| Distribution Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CURATIVE BIOTECHNOLOGY, INC. | Distribution Services |
| Entreprise privées | 2 |
|---|---|
Nobelpharma Co., Ltd.
Nobelpharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Nobelpharma Co., Ltd. provides research and development of pharmaceuticals for unmet needs. Its product line encompasses orphan drugs, medicines used for additional efficacy, and pediatric medicines. The company was founded on June 6, 2003 and is headquartered in Tokyo, Japan. | Health Technology |
Seneca Biopharma, Inc.
 Seneca Biopharma, Inc. BiotechnologyHealth Technology Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD. | Health Technology |
- Bourse
- Insiders
- Paul M. Michael
- Expérience
